Hollis-Eden management update

Hollis-Eden Pharmaceuticals Inc. (NASDAQ:HEPH), San Diego, Calif. Business: Endocrine, Autoimmune, Cancer Promoted: James Frincke to president and CEO from CSO; Frincke also becomes a director ...